ResearcherTianjin First Center HospitalActive in the last 2 years

Tao Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5787-2542; OpenAlex author ID A5018590294. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic cancer Last author DOI 10.21203/rs.3.rs-3952664/v1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guannan Sheng · 1 shared paper, 2024 · strength 0.23
- Paper PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic… DOI 10.21203/rs.3.rs-3952664/v1 ↗
Bo Ni · 1 shared paper, 2024 · strength 0.23
- Paper PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic… DOI 10.21203/rs.3.rs-3952664/v1 ↗
Yongjie Xie · 1 shared paper, 2024 · strength 0.23
- Paper PLPP2 as a metabolic and immune marker for predicting survival and enhancing response to anti-PD1 therapy in pancreatic… DOI 10.21203/rs.3.rs-3952664/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.